ATE549625T1 - Verfahren und zusammensetzungen zum nachweis einer zervixerkrankung - Google Patents
Verfahren und zusammensetzungen zum nachweis einer zervixerkrankungInfo
- Publication number
- ATE549625T1 ATE549625T1 AT05732112T AT05732112T ATE549625T1 AT E549625 T1 ATE549625 T1 AT E549625T1 AT 05732112 T AT05732112 T AT 05732112T AT 05732112 T AT05732112 T AT 05732112T AT E549625 T1 ATE549625 T1 AT E549625T1
- Authority
- AT
- Austria
- Prior art keywords
- biomarker
- methods
- compositions
- cervical disease
- cervical
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57411—Specifically defined cancers of cervix
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55649504P | 2004-03-24 | 2004-03-24 | |
PCT/US2005/009740 WO2005095964A2 (en) | 2004-03-24 | 2005-03-23 | Methods and compositions for the detection of cervical disease |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE549625T1 true ATE549625T1 (de) | 2012-03-15 |
Family
ID=34964649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05732112T ATE549625T1 (de) | 2004-03-24 | 2005-03-23 | Verfahren und zusammensetzungen zum nachweis einer zervixerkrankung |
Country Status (12)
Country | Link |
---|---|
US (5) | US7157233B2 (de) |
EP (2) | EP1756577B1 (de) |
JP (2) | JP4545189B2 (de) |
KR (3) | KR20110027823A (de) |
CN (1) | CN1957256B (de) |
AT (1) | ATE549625T1 (de) |
AU (1) | AU2005228026B2 (de) |
BR (1) | BRPI0509193B8 (de) |
CA (1) | CA2560782C (de) |
ES (1) | ES2381644T3 (de) |
MX (1) | MXPA06011020A (de) |
WO (1) | WO2005095964A2 (de) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7125663B2 (en) * | 2001-06-13 | 2006-10-24 | Millenium Pharmaceuticals, Inc. | Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer |
EP2314716A1 (de) * | 2002-08-20 | 2011-04-27 | Millennium Pharmaceuticals, Inc. | Zusammensetzungen, Kits und Verfahren zur Identifizierung, Beurteilung, Vorbeugung und Therapie von Gebärmutterhalskrebs |
US10533998B2 (en) | 2008-07-18 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
AU2005289728B2 (en) * | 2004-09-22 | 2011-11-24 | Tripath Imaging, Inc. | Methods and compositions for evaluating breast cancer prognosis |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
US7595380B2 (en) * | 2005-04-27 | 2009-09-29 | Tripath Imaging, Inc. | Monoclonal antibodies and methods for their use in the detection of cervical disease |
US7972776B2 (en) * | 2005-11-15 | 2011-07-05 | Oncohealth Corporation | Protein chips for HPV detection |
US7732166B2 (en) * | 2005-11-15 | 2010-06-08 | Oncohealth Corporation | Detection method for human pappilomavirus (HPV) and its application in cervical cancer |
US7686771B2 (en) * | 2005-12-12 | 2010-03-30 | Cytyc Corporation | Method and apparatus for obtaining aliquot from liquid-based cytological sample |
US20070140915A1 (en) * | 2005-12-12 | 2007-06-21 | Cytyc Corporation | Method and Apparatus for Obtaining Aliquot from Liquid-Based Cytological Sample |
US7632498B2 (en) * | 2005-12-19 | 2009-12-15 | Tripath Imaging, Inc. | MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease |
US7851145B2 (en) * | 2005-12-30 | 2010-12-14 | Ventana Medical Systems, Inc. | Na+, K+-ATPase expression in cervical dysplasia and cancer |
JP2009536313A (ja) | 2006-01-11 | 2009-10-08 | レインダンス テクノロジーズ, インコーポレイテッド | ナノリアクターの形成および制御において使用するマイクロ流体デバイスおよび方法 |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
EP2021113A2 (de) | 2006-05-11 | 2009-02-11 | Raindance Technologies, Inc. | Mikrofluidische vorrichtungen |
US8114615B2 (en) | 2006-05-17 | 2012-02-14 | Cernostics, Inc. | Method for automated tissue analysis |
US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
US8278056B2 (en) * | 2008-06-13 | 2012-10-02 | Oncohealth Corp. | Detection of early stages and late stages HPV infection |
US8968995B2 (en) * | 2008-11-12 | 2015-03-03 | Oncohealth Corp. | Detection, screening, and diagnosis of HPV-associated cancers |
US20080133267A1 (en) * | 2006-11-30 | 2008-06-05 | George Maltezos | System and method for individualized patient care |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US8795197B2 (en) | 2007-07-17 | 2014-08-05 | Histologics, LLC | Frictional trans-epithelial tissue disruption collection apparatus and method of inducing an immune response |
US8652067B2 (en) | 2007-07-17 | 2014-02-18 | Histologics, LLC | Frictional trans-epithelial tissue disruption and collection apparatus and method of inducing and/or augmenting an immune response |
US7838215B2 (en) * | 2007-09-25 | 2010-11-23 | Canvir, Inc. | Advanced cervical cell screening methods |
US20090132443A1 (en) * | 2007-11-16 | 2009-05-21 | Odilo Mueller | Methods and Devices for Analyzing Lipoproteins |
EP4047367A1 (de) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken |
US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US20100227335A1 (en) | 2009-03-05 | 2010-09-09 | Becton, Dickinson And Company | Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer |
US8252904B2 (en) | 2009-03-06 | 2012-08-28 | Tripath Imaging, Inc. | Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
WO2010126866A1 (en) | 2009-04-27 | 2010-11-04 | Becton Dickinson And Company | Sample preparation device and associated method |
EP2427763A4 (de) | 2009-05-07 | 2013-08-21 | Oncohealth Corp | Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen |
DE102009021734B4 (de) * | 2009-05-12 | 2012-02-02 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Diagnostische Marker für die Bestimmung der Prädisposition der Entwicklung von Gebärmutterhalskrebs und für die Bestimmung eingesetzte Oligonukleotide |
US8207651B2 (en) | 2009-09-16 | 2012-06-26 | Tyco Healthcare Group Lp | Low energy or minimum disturbance method for measuring frequency response functions of ultrasonic surgical devices in determining optimum operating point |
US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
EP2517025B1 (de) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen |
EP2521914A4 (de) | 2010-01-08 | 2013-07-10 | Oncohealth Corp | Zellbasierte hpv-immuntests mit hoher durchlaufleistung zur diagnose und abtastung von hpv-assoziierten krebsen |
JP6007106B2 (ja) * | 2010-01-14 | 2016-10-12 | インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル) | 炎症性腸疾患(ibd)及び過敏性腸症候群(ibs)の予防及び治療のための組換体プロバイオティック細菌 |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
WO2011100604A2 (en) | 2010-02-12 | 2011-08-18 | Raindance Technologies, Inc. | Digital analyte analysis |
US9044213B1 (en) | 2010-03-26 | 2015-06-02 | Histologics, LLC | Frictional tissue sampling and collection method and device |
US8900813B2 (en) * | 2010-08-17 | 2014-12-02 | Medical Diagnostic Laboratories, Llc | CIP2A as a biomarker in detection of cervical cancer |
WO2012045012A2 (en) | 2010-09-30 | 2012-04-05 | Raindance Technologies, Inc. | Sandwich assays in droplets |
WO2012065004A2 (en) * | 2010-11-12 | 2012-05-18 | Incelldx, Inc. | Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells |
WO2012090479A1 (en) * | 2010-12-28 | 2012-07-05 | Oncotherapy Science, Inc. | Mcm7 as a target gene for cancer therapy and diagnosis |
EP3859011A1 (de) | 2011-02-11 | 2021-08-04 | Bio-Rad Laboratories, Inc. | Verfahren zur bildung gemischter tröpfchen |
EP2675819B1 (de) | 2011-02-18 | 2020-04-08 | Bio-Rad Laboratories, Inc. | Zusammensetzungen und verfahren für molekulare etikettierung |
EP2686688B1 (de) | 2011-03-17 | 2019-05-08 | Cernostics, Inc. | Systeme und zusammensetzungen zur diagnose von barrett-ösophagen und verwendungsverfahren dafür |
US10445846B2 (en) | 2011-04-14 | 2019-10-15 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US10853819B2 (en) | 2011-04-14 | 2020-12-01 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
US8723640B2 (en) | 2011-08-16 | 2014-05-13 | Elwha Llc | Distillation of status data relating to regimen compliance responsive to the presence and absence of wireless signals relating to one or more threshold frequencies |
ES2847867T3 (es) | 2011-11-03 | 2021-08-04 | Tripath Imaging Inc | Métodos y composiciones para preparar muestras para inmunotinción |
GB201200178D0 (en) * | 2012-01-06 | 2012-02-22 | Cytosystems Ltd | Diagnostic method and system |
EP3264095B1 (de) * | 2012-01-26 | 2020-08-12 | Leica Biosystems Richmond, Inc. | Verfahren und zusammensetzungen zur hämatoxylin- und eosinanfärbung |
US20130210659A1 (en) | 2012-02-10 | 2013-08-15 | Andrew Watson | Molecular diagnostic screening assay |
EP2844768B1 (de) | 2012-04-30 | 2019-03-13 | Raindance Technologies, Inc. | Digitale analyse von analyten |
US10201332B1 (en) | 2012-12-03 | 2019-02-12 | Healoe Llc | Device and method of orienting a biopsy device on epithelial tissue |
KR101432174B1 (ko) * | 2013-01-22 | 2014-08-22 | 한국원자력의학원 | Cdc27을 측정하는 제제를 포함하는 방사선 저항성 또는 민감성 진단용 조성물 및 이의 용도 |
US9880156B2 (en) | 2013-04-11 | 2018-01-30 | Medite Cancer Diagnostics, Inc. | Biological specimen evaluation methods using cytology and immunology |
EP2986762B1 (de) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digitale analyse von analyten |
CN103262838B (zh) * | 2013-06-05 | 2014-04-30 | 合肥安旸生物医药有限公司 | 一种宫颈异常细胞筛查试剂盒和酶标液基细胞保存液 |
US20160187341A1 (en) * | 2013-08-08 | 2016-06-30 | The Research Foundation For The State University Of New York | Keratins as biomarkers for cervical cancer and survival |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
CA2961613A1 (en) | 2014-09-17 | 2016-03-24 | Hologic, Inc. | Method of partial lysis and assay |
CN104483472B (zh) * | 2014-12-19 | 2016-03-30 | 武汉大学 | 一种用于宫颈癌变细胞检测的诊断试剂及其制备方法 |
EP3304084B1 (de) | 2015-06-08 | 2022-03-23 | Arquer Diagnostics Limited | Verfahren und kits |
US11519916B2 (en) | 2015-06-08 | 2022-12-06 | Arquer Diagnostics Limited | Methods for analysing a urine sample |
GB201511196D0 (en) | 2015-06-25 | 2015-08-12 | Cytosystems Ltd | Monoclonal antibodies |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
US11013466B2 (en) | 2016-01-28 | 2021-05-25 | Healoe, Llc | Device and method to control and manipulate a catheter |
EP3639079A4 (de) * | 2017-06-15 | 2021-02-24 | Sunstone Scientific Limited. | Prozessaufzeichnungsobjektträger zur immunhistochemischen färbung |
US11662564B2 (en) | 2017-06-15 | 2023-05-30 | Shenzhen Prs Limited | Paraffin shield coating for microscope slide |
US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
CN111458500A (zh) * | 2020-03-03 | 2020-07-28 | 苏州百道医疗科技有限公司 | 人呼吸道上皮细胞病原细胞学检测方法及试剂盒 |
US20230184639A1 (en) * | 2020-05-29 | 2023-06-15 | Sony Group Corporation | Information processing device, information processing method, computer program, and target molecule detection system |
CN114217064A (zh) * | 2021-12-06 | 2022-03-22 | 重庆沃康生物科技有限公司 | 以p16/Ki-67、TOP2A/MCM2为靶标的宫颈癌检测试剂盒及其判读方法 |
CN114732907B (zh) * | 2022-01-21 | 2023-06-23 | 中国人民解放军军事科学院军事医学研究院 | Ddx11蛋白作为dna损伤标志蛋白或放化疗治疗肿瘤靶点的应用 |
CN114672566A (zh) * | 2022-04-13 | 2022-06-28 | 华中科技大学同济医学院附属同济医院 | Rfc4基因作为宫颈病变诊断标志物的应用 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US630332A (en) * | 1898-10-14 | 1899-08-08 | Plano Mfg Company | Truck for grain-binders. |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4820504A (en) | 1986-02-12 | 1989-04-11 | City Of Hope | Multi-specimen tissue blocks and slides |
US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
CA1340288C (en) | 1988-09-02 | 1998-12-29 | Robert Charles Ladner | Generation and selection of novel binding proteins |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5750373A (en) | 1990-12-03 | 1998-05-12 | Genentech, Inc. | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
ES2139598T3 (es) | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US5244787A (en) | 1991-01-31 | 1993-09-14 | Biogenex Laboratories | Antigen retrieval in formalin-fixed tissues using microwave energy |
DK1279731T3 (da) | 1991-03-01 | 2007-09-24 | Dyax Corp | Fremgangsmåde til udvikling af bindende miniproteiner |
EP1471142B1 (de) | 1991-04-10 | 2008-11-19 | The Scripps Research Institute | Bibliotheken heterodimerer Rezeptoren mittels Phagemiden |
WO1992019952A1 (en) * | 1991-05-07 | 1992-11-12 | Wescor, Inc. | Improved staining method for histology and cytology specimens |
US5316814A (en) | 1991-05-14 | 1994-05-31 | Ricoh Company, Ltd. | Optical information recording medium |
DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
JP2001524926A (ja) | 1991-09-18 | 2001-12-04 | アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ | オリゴマーの雑多ライブラリーの集合体を合成する方法 |
DE69233331T3 (de) | 1991-11-22 | 2007-08-30 | Affymetrix, Inc., Santa Clara | Kombinatorische Strategien zur Polymersynthese |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5346831A (en) | 1992-09-29 | 1994-09-13 | Hoffman-La Roche Inc. | Cytorich process system |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US5658636A (en) | 1995-01-27 | 1997-08-19 | Carnegie Mellon University | Method to prevent adhesion of micromechanical structures |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
EP0880598A4 (de) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Verfahren zur analyse von nukleinsäure |
US5858683A (en) | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
DE69829198T2 (de) * | 1997-10-21 | 2006-01-12 | Cancer Research Technology Ltd. | Nachweis von zellwachstumabnormalität |
US6303323B1 (en) * | 1997-10-21 | 2001-10-16 | Cancer Research Campaign Technology Limited | Detection of dysplastic or neoplastic cells using anti-MCM5 antibodies |
AU1287799A (en) | 1997-10-31 | 1999-05-24 | Affymetrix, Inc. | Expression profiles in adult and fetal organs |
US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
DE19829473C2 (de) | 1998-07-01 | 2000-08-10 | Magnus Von Knebel Doeberitz Ch | Verfahren zur frühen Diagnose von Carcinomen |
GB0018140D0 (en) * | 2000-07-24 | 2000-09-13 | Medical Res Council | Screening for abnormalities |
IT1317881B1 (it) * | 2000-07-31 | 2003-07-15 | Euroiset Italia S R L | Composizione per la neutralizzazione degli acidi inorganici e organiciforti. |
DE10063179A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern |
US7125663B2 (en) | 2001-06-13 | 2006-10-24 | Millenium Pharmaceuticals, Inc. | Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer |
US20030215917A1 (en) * | 2002-04-04 | 2003-11-20 | Mingjun Huang | Assay for evaluation of activity of compounds against HCV using a novel detection system in the HCV replicon |
ATE261126T1 (de) * | 2002-08-01 | 2004-03-15 | Mtm Lab Ag | Verfahren für lösung-basierte diagnose |
US7361460B2 (en) * | 2003-04-11 | 2008-04-22 | Digene Corporation | Approach to molecular diagnosis of human papillomavirus-related diseases |
US7595380B2 (en) * | 2005-04-27 | 2009-09-29 | Tripath Imaging, Inc. | Monoclonal antibodies and methods for their use in the detection of cervical disease |
US7632498B2 (en) * | 2005-12-19 | 2009-12-15 | Tripath Imaging, Inc. | MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease |
-
2005
- 2005-03-23 KR KR1020117002467A patent/KR20110027823A/ko not_active Application Discontinuation
- 2005-03-23 MX MXPA06011020A patent/MXPA06011020A/es active IP Right Grant
- 2005-03-23 WO PCT/US2005/009740 patent/WO2005095964A2/en active Application Filing
- 2005-03-23 EP EP05732112A patent/EP1756577B1/de active Active
- 2005-03-23 EP EP10012137A patent/EP2293069A3/de not_active Withdrawn
- 2005-03-23 KR KR1020087018983A patent/KR20080075045A/ko active Application Filing
- 2005-03-23 ES ES05732112T patent/ES2381644T3/es active Active
- 2005-03-23 JP JP2007505150A patent/JP4545189B2/ja active Active
- 2005-03-23 AT AT05732112T patent/ATE549625T1/de active
- 2005-03-23 CA CA2560782A patent/CA2560782C/en active Active
- 2005-03-23 US US11/087,227 patent/US7157233B2/en active Active
- 2005-03-23 BR BRPI0509193A patent/BRPI0509193B8/pt active IP Right Grant
- 2005-03-23 KR KR1020067022111A patent/KR100882249B1/ko not_active IP Right Cessation
- 2005-03-23 CN CN2005800163173A patent/CN1957256B/zh active Active
- 2005-03-23 AU AU2005228026A patent/AU2005228026B2/en active Active
-
2006
- 2006-08-17 US US11/506,012 patent/US7455973B2/en active Active
- 2006-09-14 US US11/521,144 patent/US7510838B2/en active Active
-
2008
- 2008-10-31 US US12/263,139 patent/US20090075300A1/en not_active Abandoned
- 2008-11-03 US US12/263,942 patent/US20090148864A1/en not_active Abandoned
-
2009
- 2009-12-01 JP JP2009273812A patent/JP2010091577A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2381644T3 (es) | 2012-05-30 |
US7455973B2 (en) | 2008-11-25 |
CA2560782A1 (en) | 2005-10-13 |
BRPI0509193A (pt) | 2007-08-28 |
CA2560782C (en) | 2013-05-21 |
CN1957256B (zh) | 2013-01-02 |
BRPI0509193B8 (pt) | 2021-07-27 |
US20070009885A1 (en) | 2007-01-11 |
US20090148864A1 (en) | 2009-06-11 |
US7157233B2 (en) | 2007-01-02 |
EP1756577A2 (de) | 2007-02-28 |
CN1957256A (zh) | 2007-05-02 |
KR20070026475A (ko) | 2007-03-08 |
WO2005095964A2 (en) | 2005-10-13 |
KR20110027823A (ko) | 2011-03-16 |
AU2005228026B2 (en) | 2011-03-24 |
JP4545189B2 (ja) | 2010-09-15 |
AU2005228026A1 (en) | 2005-10-13 |
US20050260566A1 (en) | 2005-11-24 |
US7510838B2 (en) | 2009-03-31 |
BRPI0509193B1 (pt) | 2019-03-26 |
WO2005095964A3 (en) | 2006-03-02 |
EP2293069A2 (de) | 2011-03-09 |
KR20080075045A (ko) | 2008-08-13 |
US20090075300A1 (en) | 2009-03-19 |
EP2293069A3 (de) | 2011-09-21 |
JP2007530949A (ja) | 2007-11-01 |
EP1756577B1 (de) | 2012-03-14 |
US20060286595A1 (en) | 2006-12-21 |
MXPA06011020A (es) | 2007-08-14 |
JP2010091577A (ja) | 2010-04-22 |
KR100882249B1 (ko) | 2009-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE549625T1 (de) | Verfahren und zusammensetzungen zum nachweis einer zervixerkrankung | |
WO2006036788A3 (en) | Methods and compositions for evaluating breast cancer prognosis | |
WO2007090076A3 (en) | Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor | |
ATE408032T1 (de) | Esr1 und gebärmutterhalskrebs | |
ATE393912T1 (de) | Microarrays und ihre verwendungen | |
WO2008151110A3 (en) | Molecular diagnosis and typing of lung cancer variants | |
WO2006010047A3 (en) | Methods and compositions for the detection of ovarian cancer | |
TW200745556A (en) | Biomarkers for liver fibrotic injury | |
ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
ATE384803T1 (de) | Verfahren zur schnellen bestimmung von mikrobieller dns/rns, kit dafür und verwendung des verfahrens | |
ES2788737T3 (es) | Conjunto de sondas para analizar una muestra de ADN y método para usar el mismo | |
ATE469247T1 (de) | Verfahren zum nachweis von egfr-mutationen in blutproben | |
ES2573092T3 (es) | Detección de repeticiones de multinucleótido | |
MX2010003116A (es) | Identificacion y aislamiento de celulas fetales y acido nucleico. | |
RU2019109011A (ru) | Композиции и способы с использованием фармакогеномного маркера | |
JP2019528705A5 (de) | ||
DE60327600D1 (de) | Verfahren und nukleinsäuren zur analyse von kolonkrebszellen | |
DE102007010252A8 (de) | Kontrollgene zur Normalisierung von Genexpressionsanalysedaten | |
WO2009061640A3 (en) | Hepatitis b virus (hbv) specific oligonucleotide sequences | |
JP2018512121A5 (de) | ||
WO2005118875A3 (en) | Diagnosing or predicting the course of breast cancer | |
WO2010030167A3 (en) | Method of detection and diagnosis of oral and nasopharyngeal cancers | |
ATE412053T1 (de) | Verfahren zum nachweis von krebs | |
WO2009087689A4 (en) | Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis | |
ATE439451T1 (de) | Verfahren und kit zur bestimmung von thymidinkinase-aktivität und verwendung davon |